Highlights from MolecuLight's Presence at SAWC Fall 2024
MolecuLight Corp. proudly announces the showcasing of its innovative advancements in fluorescence imaging technology at the upcoming Symposium on Advanced Wound Care (SAWC) Fall 2024. This significant event is scheduled to take place over four days, providing a platform for clinicians and researchers to discuss breakthroughs in wound care and patient management.
MolecuLight's Contributions to Wound Management
At the SAWC Fall 2024, MolecuLight will present an impressive array of 10 clinical posters, underscoring the importance of its technology in optimizing wound care practices. The presentations will cover a range of topics related to how fluorescence imaging can significantly enhance the management of wound infections, opening new avenues for patient treatment strategies.
Demonstrations of Cutting-Edge Technology
In conjunction with the clinical presentations, attendees can engage with the MolecuLight i:X® and DX™ imaging devices at Booth #431 in the Exhibition Hall. The hands-on demonstrations will allow healthcare professionals to explore the unique features that set MolecuLight apart in the realm of real-time bacterial detection and wound measurement.
Transformative Advancements in Wound Care
MolecuLight's innovative technology integrates multiple functionalities, providing clinicians with a comprehensive understanding of wound status. This facilitates better documentation of interventions, enhances treatment planning, and ultimately improves patient outcomes. As more healthcare professionals leverage these technologies, the importance of evidence-based practices in wound care becomes clearer, promoting a higher standard of care.
Clinical Insights Presented at SAWC Fall 2024
The clinical posters presented by MolecuLight include:
- Poster CR-001: "Imaging Beyond the Wound Bed: Leveraging Fluorescence Imaging of Non-Biologicals to Enhance Bacterial-Infection Management", by Dr. Charles Andersen.
- Poster CR-002: "The New Age of Wound Care: Leveraging the Synergy of Multi-modal Fluorescence and Thermal Imaging", by Dr. Charles Andersen.
- Poster CR-020: "Validation of a Digital Automatic-Depth Measurement Feature within a Multi-Modal Wound Imaging Device", presented by Dr. Laura Jones.
- Poster CR-029: "Bacterial fluorescence imaging improves chronic wound biofilm detection over standard clinical assessment and blotting", by Dr. Laura Jones.
- Poster CR-063: "Bacterial Fluorescence in the Application of Cellular Tissue Products", by Dr. Alisha Oropallo.
- Poster CR-064: "Co-localization of High Bacterial Load with Regions of Pain in Venous Leg Ulcers: Fluorescence Imaging Informs Interventions and Validates Patient Self-Reported Pain", by Dr. Alisha Oropallo.
- Poster CS-012: "Advancing Pyoderma Gangrenosum Wound Care Through Fluorescence-Guided Debridement", by Dr. Charles Andersen.
- Poster CS-115: "The Interface of Cutting-Edge Technology in Mission Sustained Injuries of U.S. Special Operations", by Dr. Charles Andersen.
- Poster CS-151: "The Association of Bacterial Autofluorescence Signals with Healing Outcomes in Diabetic Foot Ulcers", by Dr. Stephanie Woelfel.
- Poster CS-157: "Update on pressure ulcer diagnosis and management: Leveraging Fluorescence and Thermal Imaging", by Dr. Charles Andersen.
About MolecuLight
MolecuLight continues to set the standard in medical imaging with its i:X® and DX™ devices, the only Class II FDA cleared imaging solutions available for real-time bacterial detection. The clear clinical evidence backing these products has led to a growing body of research, encompassing over 100 peer-reviewed publications representing tremendous patient data. These advancements empower healthcare providers to act decisively in managing wound infections, ensuring that patients receive the best possible care.
Frequently Asked Questions
What is the significance of the MolecuLight posters at SAWC Fall 2024?
The presentations highlight the advancements and clinical evidence supporting the use of fluorescence imaging in wound care, aiming to establish this technology as a standard practice.
How can healthcare professionals interact with MolecuLight at the symposium?
Professionals can visit Booth #431 to explore demonstrations of the MolecuLight imaging devices and engage in discussions about their applications.
What makes MolecuLight's technology unique?
MolecuLight integrates bacterial detection, wound measurement, and imaging into one device, offering a comprehensive solution for clinicians.
Who are some of the featured presenters of the clinical posters?
Featured presenters include Dr. Charles Andersen, Dr. Laura Jones, Dr. Alisha Oropallo, and Dr. Stephanie Woelfel, each presenting innovative research on wound care.
What impact does MolecuLight's technology have on patient outcomes?
By providing real-time data on bacterial burden and wound status, MolecuLight enhances infection management, leading to improved patient outcomes.
